Retatrutide

Retatrutide is a synthetic peptide tri-agonist designed to activate GLP-1, GIP, and glucagon receptors. This triple-pathway activity has made it a subject of interest in advanced metabolic and obesity-related research models.

Key Research Characteristics:

• Dual incretin pathway interaction via GLP-1 and GIP receptors

• Additional activity at the glucagon receptor for expanded research potential

• Investigated for its effects on metabolic rate, nutrient processing, and energy balance in preclinical studies

• High-purity, research-grade formulation

Intended Use:
For qualified research professionals only. All products are intended for laboratory research purposes and are not approved for human use. Not for human consumption, therapeutic, or diagnostic applications.